Caprion-HistoGeneX Acquires Clinical Logistics Inc., a Virtual Central Specimen Management CRO
Caprion-HistoGeneX Acquires Clinical Logistics Inc., a Virtual Central Specimen Management CRO, and Expands its Support of Clinical Trials Specimen Logistics
PR87500
MONTREAL, Jan. 7, 2021 /PRNewswire=KYODO JBN/ --
Caprion-HistoGeneX, a leading global contract research laboratory services
provider backed by Arsenal Capital Partners, announced today the acquisition of
Clinical Logistics Inc. ("CLI"), a Virtual Central Specimen Management CRO
based in Halifax, Canada. The acquisition enables Caprion-HistoGeneX to broaden
its specimen logistics services to support the global clinical trial needs of
its pharma and biotech customers better. Focused on critical specialty
specimens with complex processing requirements such as limited stability and/or
real-time testing needs, CLI offers integrated, customizable solutions combined
with kitting and specimen logistic services for timely specimen delivery.
Logo -
https://mma.prnewswire.com/media/1396104/Caprion_Biosciences_Caprion_HistoGeneX_Logo.jpg
Logo -
https://mma.prnewswire.com/media/1396106/Caprion_Biosciences_Caprion_ClinicalLogistics_Logo1.jpg
CLI was founded in 2002 and has supported clinical trials in over 50 countries.
The company has earned a reputation for quality and customer service excellence
with some of the largest pharmaceutical companies, biotechs and CROs. Answering
an unmet need in the marketplace for high quality handling of critical samples
from clinical trial sites to the laboratory, CLI is positioned as a key player
in clinical trial logistics with a focus on specialty specimens. CLI's services
also include logistics and kitting for pharmacokinetic / pharmacodynamic
(PK/PD) and pharmacogenomics (PG) biomarkers. "We are excited to be a part of
the Caprion-HistoGeneX organization. CLI will be able to leverage the broad
capabilities and global footprint of Caprion-HistoGeneX to continue to improve
and rapidly globalize our Central Specimen Management services" said Raymond
Mah, Co-CEO and Co-Founder of CLI.
Recently recommended for ISO 13485 certification, CLI offers customized
specimen collection kits, shipment assistance at investigator sites, as well as
timely specimen shipping coordination & tracking, resulting in high recovery of
specialty specimens from investigator sites, optimal specimen integrity and
timely analyses. With its Virtual Central Specimen Management platform, CLI
eliminates the need for investigator sites to transfer specimens to a central
storage facility before their arrival at third-party testing labs. As a centralized
point of contact during clinical trials, CLI increases specimen handling
consistency and minimizes the burden of specimen tracking discrepancies.
"Caprion-HistoGeneX is excited to expand its specimen logistics and management
solutions, reinforcing our end-to-end services and ensuring specimen integrity
from collection to analysis. These services will be scaled through our
worldwide network of laboratories to provide comprehensive support to global
clinical trial sites and help alleviate common daily challenges that our
clients are facing with their complex clinical operations." said Martin
LeBlanc, CEO of Caprion-HistoGeneX.
About Caprion-HistoGeneX
Caprion-HistoGeneX is a leading provider of specialized precision medicine
laboratory services to the biopharmaceutical industry. Leveraging its
integrated analytical platforms in immunology, histopathology, proteomics, and
genomics, Caprion-HistoGeneX supports the entire drug development cycle, from
discovery to late-stage clinical trials. The company operates globally with 8
facilities located in Canada, USA, Belgium, Australia, and China.
For more information: www.caprion.com and www.histogenex.com
About Clinical Logistics Inc.
Clinical Logistics Inc. (CLI) is a contract research organization (CRO)
providing clinical trial services to global pharmaceutical and biotech
companies. The services include the provision of specimen collection supplies,
production of customized specimen identification labels and kits, and specimen
shipping coordination, management, and tracking.
For more information: www.clinicallogistics.net
About Arsenal Capital Partners
Arsenal is a leading private equity firm that specializes in investments in
middle-market healthcare and industrials companies. Since its inception in
2000, Arsenal has raised institutional equity investment funds of $5.3 billion,
has completed more than 200 platform and add-on investments, and achieved more
than 30 realizations. Arsenal invests in industry sectors in which the firm has
significant prior knowledge and experience. The firm works with management
teams to build strategically important companies with leading market positions,
high growth, and high value-add.
For more information: www.arsenalcapital.com
SOURCE: Caprion Biosciences Inc.
Media Contact: Caprion-HistoGeneX, Guylaine Galipeau, Global Marketing
Director, Caprion-HistoGeneX, ggalipeau@caprion.com
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。